Novel Oral Anticoagulant Use in the Eu5: How Are Payer Policies and Physician Preferences Shaping the Prescribing Landscape?

Value in Health - United Kingdom
doi 10.1016/j.jval.2015.09.922
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Prescribing and Using Self-Injectable Antiretrovirals: How Concordant Are Physician and Patient Perspectives?

AIDS Research and Therapy
VirologyMolecular MedicinePharmacology
2009English

Trends in Anticoagulant Prescribing: A Review of Local Policies in English Primary Care

BMC Health Services Research
Health Policy
2020English

National Trends in Ambulatory Oral Anticoagulant Use

American Journal of Medicine
Medicine
2015English

How to Define the Relative Contraindications to Oral Anticoagulant Therapy

Monaldi Archives for Chest Disease
Cardiovascular MedicinePulmonaryRespiratory MedicineCardiology
2017English

Rethinking Millennials: How Are They Shaping the Tourism Industry?

Asia Pacific Journal of Tourism Research
DevelopmentHospitality ManagementLeisurePlanningTourismGeography
2019English

Challenges in Meeting Evidence Needs of Payer, Physician, Patient and Industry Stakeholders for Novel Therapeutics

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Direct Oral Anticoagulant Use and the Incidence of Bleeding in the Very Elderly With Atrial Fibrillation

Journal of Thrombosis and Thrombolysis
Cardiovascular MedicineHematologyCardiology
2016English

Medical School Gift Restriction Policies and Physician Prescribing of Newly Marketed Psychotropic Medications: Difference-In-Differences Analysis

British Medical Journal
Medicine
2013English

Intracranial Hemorrhage During Administration of a Novel Oral Anticoagulant

Journal of Rural Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy